跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Recombinant human tumor necrosis factor-related apoptosis-inducing ligand
首页
药物
Recombinant human tumor necrosis factor-related apoptosis-inducing ligand
Recombinant human tumor necrosis factor-related apoptosis-inducing ligand
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Method for preparing mutant code cDNA of apoptosis induction ligand related to human tumor necrosis factor, and application
CN 1958794 B
申请人: CHENGDU DIAO JIUHONG PHARMACEUTICAL FACTORY
优先权: 2005
CN
Human-mouse chimeric antibody of anti-human tumor necrosis factor related apoptosis-inducing ligand receptor DR5, preparation method and uses thereof
CN 102898524 A
申请人: INST BASIC MED SCIENCES PLA
优先权: 2011
CN
Method for preparing recombinant tumor necrosis factor related apoptosis inducing ligand
CN 105441452 A
申请人: UNIV HEILONGJIANG BAYI AGRICULTURAL
优先权: 2015
CN
药物
反馈
